Search Results - "Tchang, Beverly G."

A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss by Batsis, John A., Apolzan, John W., Bagley, Pamela J., Blunt, Heather B., Divan, Vidita, Gill, Sonia, Golden, Angela, Gundumraj, Shalini, Heymsfield, Steven B., Kahan, Scott, Kopatsis, Katherine, Port, Ava, Parks, Elizabeth Prout, Reilly, Clifford A., Rubino, Domenica, Saunders, Katherine H., Shean, Ryan, Tabaza, Luai, Stanley, Abishek, Tchang, Beverly G., Gundumraj, Shivani, Kidambi, Srividya

“…Objective Dietary supplements and alternative therapies are commercialized as a panacea for obesity/weight gain as a result of the minimal regulatory…”
Get full text

Weight Loss Outcomes With Telemedicine During COVID-19 by Tchang, Beverly G, Morrison, Chenel, Kim, Joon Tae, Ahmed, Farheen, Chan, Karina M, Alonso, Laura C, Aronne, Louis J, Shukla, Alpana P

“…Amidst the COVID-19 pandemic, telemedicine was rapidly implemented to maintain patient care during quarantine. However, there is little data on how this…”
Get full text

Long‐term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study by Tchang, Beverly G., Aras, Mohini, Wu, Alan, Aronne, Louis J., Shukla, Alpana P.

“…Objective To determine the association of anti‐obesity medications (AOMs) with weight loss maintenance over 2 years. Methods This is a retrospective…”
Get full text

Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives by Tchang, Beverly G, Shukla, Alpana P, Aronne, Louis J

“…Metreleptin was recently approved by the Food and Drug Administration for the treatment of generalized lipodystrophy, a condition characterized by leptin…”
Get more information

Obesity and Diabetes by Aras, Mohini, Tchang, Beverly G., Pape, Joy

“…Obesity is the most significant risk factor for the development of diabetes. Both obesity and diabetes rates have continued to increase in tandem and pose…”
Get full text

Best Practices in the Management of Overweight and Obesity by Tchang, Beverly G., Saunders, Katherine H., Igel, Leon I.

“…Obesity is a chronic disease caused by dysregulated energy homeostasis pathways that encourage the accumulation of adiposity, which in turn results in the…”
Get full text

Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report by Zhao, Alice S., Liu, Yi, Mulvey, Joseph J., Tchang, Beverly G.

“…Osteoporosis is a metabolic bone disorder for which treatment options include antiresorptive therapies (e.g., bisphosphonates, denosumab); anabolics (e.g.,…”
Get full text

Impact of Telemedicine During the COVID‐19 Pandemic on Patient Attendance by Aras, Mohini, Tchang, Beverly G., Crawford, Andrew, Bledsoe, Melissa, Fujioka, Ken, Aronne, Louis J.

“…In response to Dr. Robert F. Kushners early observations in What COVID-19 is Teaching Us About Counseling for Weight Management (1), we providers at the…”
Get full text

Five-year Weight Loss Maintenance With Obesity Pharmacotherapy by Weintraub, Michael A, D’Angelo, Debra, Tchang, Beverly G, Sahagun, Ageline D, Andre, Clarissa, Aronne, Louis J, Shukla, Alpana P

“…Abstract Context Long-term treatment of obesity with lifestyle changes alone is unsustainable for most individuals because of several factors including…”
Get full text

An update on pharmacotherapeutic strategies for obesity by Tchang, Beverly G, Tarazi, Mohamad Sirri, Aras, Mohini, Shukla, Alpana P

“…The field of obesity medicine has evolved over the past several years. With greater understanding of its pathophysiology, obesity is regarded more as a chronic…”
Get more information

Combined medical strategies for the management of type 2 diabetes mellitus and obesity in adults by Tarazi, Mohamad Sirri, Touhamy, 2nd, Samir, Tchang, Beverly G, Shukla, Alpana P

“…Given the relationship between the pathogenesis of obesity and type 2 diabetes mellitus (T2DM) as well as their significant health consequences, treatment…”
Get more information

The Independent Risk of Obesity and Diabetes and Their Interaction in COVID‐19: A Retrospective Cohort Study by Tchang, Beverly G., Askin, Gulce, Sahagun, Ageline, Hwang, Jonathan, Huang, Hao, Mendelsohn Curanaj, Felicia A., Seley, Jane J., Safford, Monika M., Alonso, Laura C., Aronne, Louis J., Shukla, Alpana P.

“…Objective This study aimed to assess whether diabetes mellitus (DM) or obesity is an independent risk factor for severe coronavirus disease 2019 (COVID‐19)…”
Get full text

Surgical and Nonsurgical Weight Loss for Patients with Obstructive Sleep Apnea by Saunders, Katherine H., Igel, Leon I., Tchang, Beverly G.

“…A strong association exists between excess weight and obstructive sleep apnea (OSA), and most patients with OSA have elevated body mass index. Weight loss is…”
Get full text

An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity by Tchang, Beverly G, Abel, Brittany, Zecca, Christina, Saunders, Katherine H, Shukla, Alpana P

“…: Obesity is a chronic disease caused by dysfunctional neurohormonal systems that result in excess weight, adiposopathy, and increased risk for many…”
Get more information

Medical Weight‐Loss Outcomes in Patients Receiving Concomitant Psychotropic Medication: A Retrospective Cohort Study by Shukla, Alpana P., Mandel, Lindsay S., Tchang, Beverly G., Litman, Ethan, Cadwell, Joshua, Kumar, Rekha B., Waitman, Jonathan, Igel, Leon I., Christos, Paul, Aronne, Louis J.

“…Objective This study aimed to elucidate medical weight‐loss outcomes in patients unexposed or exposed to psychotropic medication(s). Methods This retrospective…”
Get full text

2097-P: Weight Loss Maintenance in Medically Managed Patients with Obesity by TCHANG, BEVERLY G., ARAS, MOHINI, MANDEL, LINDSAY, IGEL, LEON I., KUMAR, REKHA, SAUNDERS, KATHERINE H., WAITMAN, JONATHAN, ARONNE, LOUIS, SHUKLA, ALPANA

“…Background: The efficacy of anti-obesity medications in combination with lifestyle modification is robustly supported by randomized controlled trials, but…”
Get full text

Preadmission predictors of severe COVID-19 in patients with diabetes mellitus by Shukla, Alpana P., Tchang, Beverly G., Lam, Tiffany, Steller, Ian, Touhamy, Samir, Askin, Gulce, Mendelsohn Curanaj, Felicia A., Seley, Jane J., Lorber, Daniel, Safford, Monika M., Aronne, Louis J., Alonso, Laura C.

“…To explore predictors of severe COVID-19 disease in patients with diabetes hospitalized for COVID-19. This is a retrospective observational study of adults…”
Get full text

Letter to the Editor of ObesityPillars from the Obesity Medicine Fellowship Council by Ahn, Yoon Ji, Taormina, John Michael, Tchang, Beverly G., Srivastava, Gitanjali, Schmidt, Stacy L., Kaplan, Lee M.

Get full text

Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study by Chukir, Tariq, Mandel, Lindsay, Tchang, Beverly G., Al- Mulla, Nada A., Igel, Leon I., Kumar, Rekha B., Waitman, Jonathan, Aronne, Louis J., Shukla, Alpana P.

“…It is unknown whether weight loss outcomes differ with metformin monotherapy in patients with obesity with or without type 2 diabetes (T2DM)/prediabetes…”
Get full text

Obesity Pharmacotherapy: a Review of Current Practices and Future Directions by Schmitz, Sarah, Tchang, Beverly G., Shukla, Alpana P.

“…Purpose of Review The aim of this article is to review the current pharmacologic treatment options available for the treatment of obesity. The efficacy of each…”
Get full text